PHARMA SIGNALOPEN RESEARCH PLATFORM →
COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Sarepta Therapeutics

Biotech focused on Duchenne muscular dystrophy and other rare neuromuscular diseases.

TICKERSRPT
HEADQUARTERSMassachusetts, USA
STAGEApproved
ACTIVE TRIALS13

Therapeutic areas

Neuromuscularrare diseases

Selected products and programs

Exondys 51Vyondys 53

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4

Phase 3 · Active Not Recruiting · Limb-girdle Muscular Dystrophy

Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy

Phase 1 · Recruiting · Myotonic Dystrophy 1

A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease

Phase 1 · Recruiting · Huntington's Disease

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

Phase 1 · Recruiting · Duchenne Muscular Dystrophy

Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1

Phase 1 · Recruiting · Muscular Dystrophy, Facioscapulohumeral

A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

Phase 3 · Active Not Recruiting · Muscular Dystrophy, Duchenne

Selected patent records

US RE47691

golodirsen · Expires 2028-06-28

US RE48468

eteplirsen · Expires 2028-10-27

US RE47769

eteplirsen · Expires 2029-02-02

US 10337003

eteplirsen · Expires 2034-03-14

US 10364431

eteplirsen · Expires 2034-03-14

US 9506058

eteplirsen · Expires 2034-03-14

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier
/companies/sarepta-therapeutics/
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record